Global Drug Discovery Informatics Market 2024-2028
The drug discovery informatics market is forecasted to grow by USD 7287.7 mn during 2023-2028, accelerating at a CAGR of 18.17% during the forecast period. The report on the drug discovery informatics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing r and d investments by pharmaceutical and biopharmaceutical companies, drug discovery with reduced time and cost by using in-silico modeling tools, and increasing outsourcing activities for drug discovery.
Technavio's drug discovery informatics market is segmented as below:
By Application
- Discovery informatics
- Development informatics
By Solution
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing number of clinical trials as one of the prime reasons driving the drug discovery informatics market growth during the next few years. Also, rising adoption of AI tools and rising emergence in personalized medicine will lead to sizable demand in the market.
The report on the drug discovery informatics market covers the following areas:
- Drug discovery informatics market sizing
- Drug discovery informatics market forecast
- Drug discovery informatics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug discovery informatics market vendors that include Aragen Life Sciences Pvt. Ltd., Certara Inc., Charles River Laboratories International Inc., ChemAxon Ltd., ChemBridge Corp., Collaborative Drug Discovery Inc., Cresset BioMolecular Discovery Ltd., Curia Global Inc., Dassault Systemes SE, Eurofins Scientific SE, Evotec SE, Infosys Ltd., Insilico Medicine, International Business Machines Corp., Jubilant Pharmova Ltd., Melissa Inc., OpenEye Scientific Software Inc., PerkinElmer Inc., Schrodinger Inc., Selvita SA, and Thermo Fisher Scientific Inc.. Also, the drug discovery informatics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.